Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Chemotherapy (Florence, Italy)
|
June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer
A Onyenadum, H Gogas, P Kosmidis, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
E Briasoulis, G Fountzilas, A Bamias, et al.
Anti-Cancer Drugs
|
January 19, 2005
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
E Razis, D Skarlos, E Briasoulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
P A Kosmidis, H P Kalofonos, C Christodoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
A Psyrri, K T Kalogeras, R Kronenwett, et al.
Cancer Chemotherapy and Pharmacology
|
October 26, 2012
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
K Pliarchopoulou, K T Kalogeras, R Kronenwett, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping
J Sgouros, A Eliades, K Papadopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, P Papakostas, U Dafni, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece
S Manolakou, N Tsoukalas, E Saloustros, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Chemotherapy (Florence, Italy)
|
June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer
A Onyenadum, H Gogas, P Kosmidis, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
E Briasoulis, G Fountzilas, A Bamias, et al.
Anti-Cancer Drugs
|
January 19, 2005
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
E Razis, D Skarlos, E Briasoulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
P A Kosmidis, H P Kalofonos, C Christodoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
A Psyrri, K T Kalogeras, R Kronenwett, et al.
Cancer Chemotherapy and Pharmacology
|
October 26, 2012
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
K Pliarchopoulou, K T Kalogeras, R Kronenwett, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping
J Sgouros, A Eliades, K Papadopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, P Papakostas, U Dafni, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece
S Manolakou, N Tsoukalas, E Saloustros, et al.
Page
of 2